CM 6336
Alternative Names: CM-6336Latest Information Update: 07 Jun 2024
At a glance
- Originator CalciMedica
- Class Anti-inflammatories; Antirheumatics; Small molecules
- Mechanism of Action ORAI1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pancreatitis; Rheumatoid arthritis